Wen‐Juei Jeng

Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen–negative chronic hepatitis B

Wen‐Juei Jeng, Yi‐Cheng Chen, Rong‐Nan Chien et al. · Hepatology · 2017 · 322 citations

Pharmacy, Pharmacotherapy, Hepatic Pharmacotherapy +16

Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients

Wen‐Juei Jeng, I‐Shyan Sheen, Yi‐Cheng Chen et al. · Hepatology · 2013 · 223 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Prognostic Value of the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Lung Adenocarcinoma Classification on Death and Recurrence in Completely Resected Stage I Lung Adenocarcinoma

Jung‐Jyh Hung, Wen‐Juei Jeng, Teh‐Ying Chou et al. · Annals of Surgery · 2013 · 207 citations

Medicine, Oncology, Surgery +17

A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease

Manuel Romero‐Gómez, Eric Lawitz, R. Ravi Shankar et al. · Journal of Hepatology · 2023 · 192 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)

Grishma Hirode, Hannah Choi, Chien‐Hung Chen et al. · Gastroenterology · 2021 · 187 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15